Recall: Endo Pharmaceuticals Inc. Robaxin (methocarbamol Tablets, USP) 750mg Tablets
On 2018-09-28, the FDA announced that Endo Pharmaceuticals is conducting a recall on Robaxin (methocarbamol Tablets, USP) 750mg Tablets due to a possible lack of proper labeling. The recalled products were sold under the brand name(s) Endo Pharmaceuticals Inc. during an unspecified time period throughout the regions shown in the map below.
In recent months, there have been 3 drugs recalls due to potential lack of proper labeling, including montelukast sodium tablets, usp 10mg, children's advil suspension bubble gum flavored 4 fl oz bottle and more. Additionally, there have been 27 drug and medical device recalls due to other health hazards as well as 63 food recalls.
Company Contact Information:
Name: Endo Pharmaceuticals
Do you work for a company involved with this recall? Contact us to learn how you can control data, information and ads shown on this page.
Detailed Recall Information
Regions Where Sold: Because the region was not specified, it is assumed that this product was available nationwide.
Product Description: Robaxin (methocarbamol tablets, USP) 750mg Tablets
Brand Name(s): Endo Pharmaceuticals Inc.
Reason for Recall: Due to Incorrect Daily Dosing Information on Label
Official Recall Date: 2018-09-28
Additional information provided by the FDA.gov:
Endo International plc (NASDAQ: ENDP) today announced that one of its operating companies, Endo Pharmaceuticals Inc., is voluntarily recalling two lots of Robaxin (methocarbamol tablets, USP) 750mg Tablets 100 Count Bottle pack to the consumer level. The products have been found to have incorrect daily dosing information on the label due to a labeling error which misstates the daily dose as "two to four tablets four times daily" rather than the correct dosage of "two tablets three times daily." (see picture below for location of incorrect text). Read More.
More information may be available at FDA.gov
Latest Safety Recalls
Select image for details, including additional styles.
Sources may include Food & Drug Administration (FDA), United States Department of Agriculture (USDA), Health Canada and companies involved with this or a related recall.